コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 fter single febrile, unprovoked seizures, or status epilepticus).
2 neuroprotective actions in rodent models of status epilepticus.
3 ocampus was active throughout the episode of status epilepticus.
4 hippocampal neuronal death in vivo following status epilepticus.
5 ility; however, it reduced susceptibility to status epilepticus.
6 d after pilocarpine- and kainic acid-induced status epilepticus.
7 out the process of epileptogenesis following status epilepticus.
8 glia following excitatory injury elicited by status epilepticus.
9 65 did not predict progression to refractory status epilepticus.
10 trongly resembles clinical EEG recordings of status epilepticus.
11 53 (29.9%); 96 cases (54.2%) were refractory status epilepticus.
12 reduced mortality, severity, and duration of status epilepticus.
13 the hippocampus of humans who died following status epilepticus.
14 cond-line drug for benzodiazepine-refractory status epilepticus.
15 psy after intra-amygdala kainic acid-induced status epilepticus.
16 rologic outcomes in patients with convulsive status epilepticus.
17 ment in auditory discrimination had incident status epilepticus.
18 ndard care alone in patients with convulsive status epilepticus.
19 s in the context of a stroke-like episode or status epilepticus.
20 patients admitted to the ICU for convulsive status epilepticus.
21 enic injuries, including pilocarpine-induced status epilepticus.
22 us epilepticus can be inhibited to terminate status epilepticus.
23 ated patients with nonprincipal diagnoses of status epilepticus.
24 patients admitted to the ICU for convulsive status epilepticus.
25 especially in patients with complex partial status epilepticus.
26 considered in the evaluation of the child in status epilepticus.
27 ic infusions to be weaned with resolution of status epilepticus.
28 considered first-line therapy for pediatric status epilepticus.
29 igh suspicion for nonconvulsive seizures and status epilepticus.
30 considered in young children with recurrent status epilepticus.
31 n 2 pediatric patients with super-refractory status epilepticus.
32 sful anaesthetic liberation after refractory status epilepticus.
33 1% had nosocomial infections diagnosed after status epilepticus.
34 the withdrawal of anaesthetics in refractory status epilepticus.
35 lectrographic seizures, or 3) electrographic status epilepticus.
36 ably well on our cohort of ICU patients with status epilepticus.
37 r the definitions of seizures, epilepsy, and status epilepticus.
38 reduced mortality, severity, and duration of status epilepticus.
39 n, and mortality observed during focal onset status epilepticus.
40 f activation in relation to the induction of status epilepticus.
41 nt in the treatment of paediatric convulsive status epilepticus.
42 ting an EEG pattern concerning for incipient status epilepticus.
43 m, and olfactory system in the initial phase status epilepticus.
44 ond-line management of paediatric convulsive status epilepticus.
47 nding prevalence was high in post convulsive status epilepticus (33.5%, 20.2%, and 32.9%), CNS infect
48 ollment of patients with a second episode of status epilepticus accounted for 16 additional instances
49 etrospective review of adults with new-onset status epilepticus admitted to Mayo Clinic, Rochester MN
52 rom randomisation to cessation of convulsive status epilepticus, analysed in the modified intention-t
53 ractive shifts in neuronal activity (kainate status epilepticus and CaMKIIa Gq DREADD activation) tri
54 arpine-induced status epilepticus, and after status epilepticus and daily treatment beginning 24 hour
55 e associated with higher rates of refractory status epilepticus and death (with every 1mg/L: odds rat
57 ease progression between 2 and 5 months post-status epilepticus and drastically reduced the frequency
58 y and demonstrate that blocking P2Y(1) after status epilepticus and during epilepsy has potent antico
59 r research to enable early identification of status epilepticus and efficacy of anti-epileptic drugs
61 ndidate for the treatment of drug-refractory status epilepticus and epilepsy.SIGNIFICANCE STATEMENT T
64 en electrographic seizures or electrographic status epilepticus and mortality or short-term neurologi
65 Respondents continue to rely on myoclonic status epilepticus and neuroimaging, which were favored
66 evels in the contralateral hippocampus after status epilepticus and resulted in more frequent spontan
67 rence and sedation and times to cessation of status epilepticus and return to baseline mental status.
68 orn up to 5 weeks before pilocarpine-induced status epilepticus and these cells were then eliminated
69 ous anaesthesia without developing recurrent status epilepticus, and a wean failure as either recurre
71 us asthmaticus, alcohol withdrawal syndrome, status epilepticus, and acute behavioral psychologic dis
72 ce, in mice 5 days after pilocarpine-induced status epilepticus, and after status epilepticus and dai
73 140 patients with encephalitis, seizures or status epilepticus, and antibodies to unknown neuropil a
74 cal ventilation for more than 24 hours after status epilepticus, and arterial hypotension requiring v
75 described as a strategy for super-refractory status epilepticus, and better evidence for their use ma
76 , fosphenytoin, and valproate in established status epilepticus, and here we describe our results aft
77 erline common EEG seizure onset patterns and status epilepticus, and postulates a role for synaptic p
78 Recommendations regarding nutrition during status epilepticus are lacking, and it is unclear whethe
79 ses of truly refractory and super-refractory status epilepticus are seen infrequently at any given in
81 ity during anaesthetic weaning in refractory status epilepticus as predictors of successful weaning f
82 onstandardized and age-standardized rates of status epilepticus as the underlying cause of death in t
83 -6B and HHV-7 primary infection with febrile status epilepticus as well as the role of reactivation o
84 of MRI vs. computed tomography in new-onset status epilepticus, as well as high rates of identificat
85 on locomotor rhythmogenesis and touch-evoked status epilepticus associated with markedly impaired KCC
86 rbital and midazolam significantly increased status epilepticus-associated neuronal injury in various
87 atment, and critically, that the duration of status epilepticus at the time of treatment is an import
88 trols in vehicle-treated mice 2 months after status epilepticus, but remained at only 63% of controls
89 he primary efficacy outcome was cessation of status epilepticus by 10 minutes without recurrence with
91 ability to accurately predict the outcome of status epilepticus by measures of discrimination and cal
93 ium-permeable AMPA receptors modified during status epilepticus can be inhibited to terminate status
95 ing fatal etiology, duration and severity of status epilepticus, Charlson comorbidity index, and trea
96 logy, Status Epilepticus Severity Score, and status epilepticus classification per the Status Epilept
98 nce was particularly high in post convulsive status epilepticus, CNS infection, and post cardiac arre
102 line received more calories and proteins per status epilepticus day, and increasing nutritional suppo
103 relative risk, 1.01; 95% CI, 1.001-1.01) per status epilepticus day, independent of potential confoun
104 s a condition characterized by recurrence of status epilepticus despite use of deep general anesthesi
105 atios of nonconvulsive seizure/nonconvulsive status epilepticus detected by continuous electroencepha
106 ither nonconvulsive seizure or nonconvulsive status epilepticus detected by routine electroencephalog
107 alizations, likely reflecting an increase in status epilepticus diagnoses through improved diagnostic
110 failures at ICU admission and occurrence of status epilepticus during ICU stay were not associated w
111 ts), and focal epilepsies with an electrical status epilepticus during slow sleep-like EEG pattern (s
113 ence of nonconvulsive seizure, nonconvulsive status epilepticus, either nonconvulsive seizure or nonc
114 infection, seizures including non-convulsive status epilepticus, endocrinopathy, or thiamine deficien
115 lence of nonconvulsive seizure/nonconvulsive status epilepticus/epileptiform activity and odds ratio
116 o provide updates on identifying children in status epilepticus, etiologic considerations, and the ra
118 ratio, 8.85; 95% CI, 4.87-16.08), myoclonic status epilepticus (false-positive rate, 0.05; 95% CI, 0
119 ecorded prospectively demographics, clinical status epilepticus features, treatment, and outcome at d
123 dy reviews protocols for treating convulsive status epilepticus from 33 emergency medical services sy
124 e is a long-standing hypothesis that febrile status epilepticus (FSE) can cause brain injury, particu
127 coma is associated with poorer outcome after status epilepticus; furthermore, it portends higher infe
128 0 min) febrile seizures; febrile or afebrile status epilepticus (>30 min); or with clusters of two or
129 of drug-resistant epilepsies and refractory status epilepticus has been further defined and is expec
130 conditions, which in their most severe form, status epilepticus, have a high mortality rate if not qu
131 related mortality and the marked increase in status epilepticus hospitalizations, likely reflecting a
132 se drugs are administered after the onset of status epilepticus, however, their effect on seizure sev
133 tergic synaptic transmission associated with status epilepticus; however, gamma-aminobutyric acidergi
136 This review discusses the management of status epilepticus in children, including both anticonvu
141 vestigated P2X7R responses after focal-onset status epilepticus in mice, comparing changes in the dam
143 a paucity of data on patients with new-onset status epilepticus in patients without a prior history o
146 the 21-year study period, the prevalence of status epilepticus in primary admissions of septic patie
147 lsant for treatment of paediatric convulsive status epilepticus in the UK; however, some evidence sug
148 We will present the current definition of status epilepticus, including a recently modified operat
151 tigate a potential role of Orai1 channels in status epilepticus induced by chemoconvulsants, we exami
152 made in a well-characterized mouse model of status epilepticus-induced epilepsy (systemic pilocarpin
153 at desirable and undesirable consequences of status epilepticus-induced TrkB activation are mediated
155 sistent across two different mouse models of status epilepticus (intra-amygdala kainic acid and intra
171 ndicate that increased calorie intake during status epilepticus is independently associated with unfa
173 Benzodiazepine-refractory, or established, status epilepticus is thought to be of similar pathophys
174 od-brain barrier pathology in rats following status epilepticus, late electrocorticography to identif
177 arbital had a similar exacerbating effect on status epilepticus-like activity, while a high concentra
179 stimulation of GABAergic interneurons in the status epilepticus-like state, actually enhanced epilept
183 in as seizures progressed and at the peak of status epilepticus, motor and somatosensory cortex, retr
185 eadache that progressed to hydrocephalus and status epilepticus necessitating a medically induced com
186 six had encephalitis with seizures (one with status epilepticus needing pharmacologically induced com
187 tives was described in patients with stroke, status epilepticus, neurodegenerative disorders, neurotr
189 EG) confirmed status epilepticus, refractory status epilepticus on day 1, "super-refractory" status e
190 The rate of progression to EEG-confirmed status epilepticus on the first day was lower in the hyp
192 rs; five male patients) developed refractory status epilepticus or epilepsia partialis continua along
193 icus, and a wean failure as either recurrent status epilepticus or the resumption of anaesthesia for
197 en daily calorie intake and outcome in adult status epilepticus patients deriving from a 5-year cohor
198 population-standardized hospitalizations for status epilepticus per 100 000 persons increased by 56.4
199 ths to younger than 18 years with convulsive status epilepticus presenting to 1 of 11 US academic ped
201 logistic regression analysis disclosed that status epilepticus, psychosis and cognitive dysfunction
202 For this purpose, we used two distinct post-status epilepticus rat models, in which epilepsy was ind
203 agents for refractory generalised convulsive status epilepticus, rather than additional trials of sec
204 was reduced to 63% of controls 5 days after status epilepticus, recovered to 93% of controls in vehi
206 electroencephalographically (EEG) confirmed status epilepticus, refractory status epilepticus on day
207 al cross-sectional studies including 408 304 status epilepticus-related hospital visits using general
208 ere used to estimate population-standardized status epilepticus-related hospitalization rates using I
209 , yet limited data exist detailing trends in status epilepticus-related hospitalizations and mortalit
211 connect exists between the relatively stable status epilepticus-related mortality and the marked incr
215 6 months to under 18 years, with convulsive status epilepticus requiring second-line treatment, were
216 tus epilepticus on day 1, "super-refractory" status epilepticus (resistant to general anesthesia), an
217 n, adults, and older adults with established status epilepticus respond similarly to levetiracetam, f
218 rarchy in approach in controlling refractory status epilepticus (RSE) and super-refractory status epi
219 isolating brain capillaries from rats after status epilepticus (SE) and in chronic epileptic (CE) ra
220 the onset of severe acute seizures known as status epilepticus (SE) are crucial for the process of e
222 ally relevant question is whether early post-status epilepticus (SE) evoked chloride dysregulation is
223 neuron precursors into the hippocampus after status epilepticus (SE) greatly restrained SRS and allev
224 cial for restraining seizures, cannot thwart status epilepticus (SE) induced neurodegeneration or dow
231 , we used a rat model of pilocarpine-induced status epilepticus (SE) to investigate HIF-1alpha expres
234 ss plays in determining KCC2 activity during status epilepticus (SE) using knockin mice in which S940
237 roduced in 50% of rats reduced threshold for status epilepticus (SE), accelerated epileptogenesis, an
239 insults, such as trauma, stroke, anoxia, and status epilepticus (SE), cause multiple changes in synap
240 mensional inflammatory response ensues after status epilepticus (SE), driven partly by cyclooxygenase
241 found that in the mouse pilocarpine model of status epilepticus (SE), systemic administration of TG6-
242 to adult-born DGCs after pilocarpine-induced status epilepticus (SE), whereas normotopic DGCs synapse
249 nterquartile range, 42-76], 55% male, median Status Epilepticus Severity Score 3 [interquartile range
250 iscrimination and calibration indicated that Status Epilepticus Severity Score performed reasonably w
253 t demographics, status epilepticus etiology, Status Epilepticus Severity Score, and status epilepticu
254 of anesthetic drugs, mechanical ventilation, Status Epilepticus Severity Score, refractoriness of sei
255 ance: Prolonged seizures in super-refractory status epilepticus (SRSE) have been shown to cause neuro
257 ome measures of occurrence of first seizure, status epilepticus, stroke-like episode, and death.
258 parameters resulted in immediate relapse of status epilepticus, suggesting a pivotal role of deep br
259 orth London, UK (the north London convulsive status epilepticus surveillance study cohort; NLSTEPSS).
260 ined as frequency of complications following status epilepticus termination and return to premorbid f
262 ative risks of complications occurring after status epilepticus termination for no return to premorbi
264 epticus (SRSE) is a life-threatening form of status epilepticus that continues or recurs despite 24 h
265 ar-old boy with a prolonged super-refractory status epilepticus that eventually resolved after commen
267 ate - in children and adults with convulsive status epilepticus that was unresponsive to treatment wi
268 text of benzodiazepine-refractory convulsive status epilepticus, the anticonvulsant drugs levetiracet
269 e showed that, following pilocarpine-induced status epilepticus, there are two independent changes in
270 during successful anaesthetic liberation in status epilepticus; these findings are absent in patient
271 d in guidelines for management of refractory status epilepticus; this is, however, based on weak evid
272 agents are typically titrated in refractory status epilepticus to achieve either seizure suppression
276 nical trials, such as the ESETT (Established Status Epilepticus Treatment Trial), compare effectivene
277 Among pediatric patients with convulsive status epilepticus, treatment with lorazepam did not res
279 rom randomisation to cessation of convulsive status epilepticus was 35 min (IQR 20 to not assessable)
285 hospitalizations were categorized by whether status epilepticus was the principal diagnosis, whether
287 l of acquired epilepsy induced by electrical status epilepticus, we show that oxidative stress occurs
288 ial instability emerged around 6 weeks after status epilepticus, well after the onset of chronic seiz
292 e found that 48% of children presenting with status epilepticus were unresponsive to benzodiazepine t
293 They develop epilepsy after experiencing status epilepticus when naturally exposed to domoic acid
294 ay be a treatment option in super-refractory status epilepticus when other treatment options have fai
295 270 critically ill patients with convulsive status epilepticus who were receiving mechanical ventila
296 ients with 11 episodes of serial seizures or status epilepticus, who underwent MRI and (18)F-FET PET,
297 on and diagnostic evaluation of the child in status epilepticus will help identify causes, which may
298 er proband subsequently developed refractory status epilepticus, with dramatic electroclinical improv
299 echanism underlying benzodiazepine-resistant status epilepticus, with relevance to how this life-thre
300 e (FIRES), a subtype of new onset refractory status epilepticus, with the recombinant interleukin-1 (